-based immunotherapy in osteosarcoma and suggest that baseline immune status may determine clinical and immunological responses to combination therapy. Pet dogs with osteosarcoma represent a parallel population to pediatric osteosarcoma patients. These findings may inform future pediatric osteosarcoma clinical trials and patient stratification.
No takes yet. Share an insight, caveat, or question.
Mason et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: